Last reviewed · How we verify
Edesa Biotech Inc. — Portfolio Competitive Intelligence Brief
0 marketed
0 filed
0 Phase 3
3 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
Therapeutic area mix
- Dermatology · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Allergan · 1 shared drug class
- Balmoral Medical company · 1 shared drug class
- Bausch & Lomb Incorporated · 1 shared drug class
- Cerium Pharmaceuticals, Inc. · 1 shared drug class
- Dr. Reddys Laboratories, SA · 1 shared drug class
- Evon Medics LLC · 1 shared drug class
- Federal University of São Paulo · 1 shared drug class
- Kala Pharmaceuticals, Inc. · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Edesa Biotech Inc.:
- Edesa Biotech Inc. pipeline updates — RSS
- Edesa Biotech Inc. pipeline updates — Atom
- Edesa Biotech Inc. pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Edesa Biotech Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/edesa-biotech-inc. Accessed 2026-05-16.